Boch, Tobias

Human haematopoietic stem cell lineage commitment is a continuous process

Velten, L., Haas, S. F., Raffel, S., Blaszkiewicz, S., Islam, S., Hennig, B. P., Hirche, C., Lutz, C., Buss, E. C., Nowak, D., et al. (2017) · Nature Cell Biology

Hematopoietic Stem Cell TransplantationSingle-cell and spatial transcriptomics

Cited by 925

Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states

Triana, S., Vonficht, D., Jopp-Saile, L., Raffel, S., Lutz, R., Leonce, D., Antes, M., Hernández-Malmierca, P., Ordoñez-Rueda, D., Ramasz, B., et al. (2021) · Nature Immunology

Single-cell and spatial transcriptomicsAdvanced Proteomics Techniques and Applications

Cited by 195

Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples

Heldt, S., Prattes, J., Eigl, S., Spiess, B., Flick, H., Rabensteiner, J., Johnson, G., Prüller, F., Wölfler, A., Niedrist, T., et al. (2018) · Journal of Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 110

Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention

Michaeli, D. T., Michaeli, J. C., Albers, S., Boch, T., & Michaeli, T. (2023) · American Journal of Cardiovascular Drugs

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 109

Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study

Boch, T., Reinwald, M., Spiess, B., Liebregts, T., Schellongowski, P., Meybohm, P., Rath, P.-M., Steinmann, J., Trinkmann, F., Britsch, S., et al. (2018) · Journal of Critical Care

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 61

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany

Michaeli, D. T., Michaeli, J. C., Boch, T., & Michaeli, T. (2023) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 23

Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy

Michaeli, D. T., Michaeli, J. C., Boch, T., & Michaeli, T. (2022) · Clinical Drug Investigation

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 20

Evaluating the use of PCR for diagnosing invasive aspergillosis

Buchheidt, D., Reinwald, M., Hofmann, W.-K., Boch, T., & Spiess, B. (2017) · Expert Review of Molecular Diagnostics

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 17

Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab

Michaeli, D. T., Michaeli, J. C., Boch, T., & Michaeli, T. (2022) · European Heart Journal

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 9

Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK

Michaeli, D. T., Michaeli, J. C., Boch, T., & Michaeli, T. (2022) · European Heart Journal

Health Systems, Economic Evaluations, Quality of LifeFatty Acid Research and Health

Cited by 1